Age-related leukocyte and cytokine patterns in community-acquired bronchopneumonia

Ami Ballin1, Alla Osadchy, Alla Osdachi

  • 1Department of Pediatrics, Wolfson Medical Center, Holon, Israel. ballin@wolfson.health.gov.il

Insights

Community-acquired bronchopneumonia shows higher leukocyte counts in children than adults. Inflammatory cytokine levels were similar, but immune responses appear age-dependent.

Area of Science:

  • Pediatric and adult infectious diseases
  • Immunology
  • Hematology

Background:

  • Community-acquired bronchopneumonia (CABP) often presents with extreme leukocytosis in children, unlike adults.
  • Limited data exists on serum inflammatory cytokine differences between pediatric and adult CABP patients.

Purpose of the Study:

  • To compare leukocyte counts and serum inflammatory cytokine levels in pediatric and adult patients diagnosed with CABP.

Main Methods:

  • Prospective evaluation of pediatric and adult patients admitted for CABP based on clinical and chest X-ray findings.
  • Analysis of complete blood counts and serum concentrations of granulocyte colony-stimulating factor (G-CSF), interleukins (IL-6, IL-8, IL-10), interferon-gamma, tumor necrosis factor, matrix metalloproteinase-9 (MMP-9), and intercellular adhesion molecule-1.

Main Results:

  • Mean leukocyte counts were significantly higher in children (21,018/mm3) than adults (12,628/mm3).
  • Age was inversely correlated with leukocyte and platelet counts in the pediatric group.
  • While overall cytokine levels did not differ significantly, age correlated positively with MMP-9, IL-8, and G-CSF.

Conclusions:

  • The immune response in community-acquired bronchopneumonia exhibits age-dependent characteristics.
  • Leukocyte count differences in CABP between children and adults may be influenced by age-related immune responses.
Abstract

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation